Effects of <scp>COVID</scp>‐19 pandemic on malignant melanoma diagnosis

Villani, Alessia; Scalvenzi, Massimiliano; Fabbrocini, Gabriella; Fornaro, Luigi; Guerrasio, Gianluca; Potestio, Luca

doi:10.1111/jdv.18545

Cited by 10 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In particular, melanoma and non-melanoma skin cancers can be distinguished. 76 Even if several studies reported the reduction in the diagnosis of skin tumors during the pandemic, [77][78][79][80][81][82][83] few data are available on their diagnosis and management using telemedicine. Jobbágy et al showed that asynchronous teledermatology was an accurate skin cancer screening system during the first wave of the COVID-19 pandemic, examining 749 patients with 799 lesions using a mobile phone application.…”

Section: Teledermatology and Skin Cancersmentioning

confidence: 99%

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

Ruggiero¹,

Fabbrocini²,

Villani³

et al. 2022

CCID

Self Cite

View full text Add to dashboard Cite

Teledermatology represented one of the most important and useful tools during the COVID-19 pandemic era. Indeed, due to the severe restriction, and to reduce the spread of the infection, different measures were applied among different countries and hospitals to ensure a continuity of care for patients. In this scenario, teledermatology played a central role, especially in the management of patients suffering from chronic inflammatory skin diseases. The aim of this narrative review is to describe the role of teledermatology during the COVID-19 pandemic to analyze main strengths and limitations of this tool, as well as to provide future perspectives in clinical applications.

show abstract

Section: Teledermatology and Skin Cancersmentioning

confidence: 99%

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

Ruggiero¹,

Fabbrocini²,

Villani³

et al. 2022

CCID

Self Cite

View full text Add to dashboard Cite

show abstract

“…The study selection process is summarized in Figure 1 . From a total of 466 records, 25 studies were incorporated in our data analysis models [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ].…”

Section: Resultsmentioning

confidence: 99%

A Meta-Analysis on the Impact of the COVID-19 Pandemic on Cutaneous Melanoma Diagnosis in Europe

Seretis

Bounas

Gaitanis

et al. 2022

Cancers

View full text Add to dashboard Cite

The COVID-19 pandemic has been the epicenter of healthcare attention globally for the past two years, and large-scale adaptations in healthcare provision have been required. This study aimed to investigate the impact of the pandemic and the resulting lockdowns on cutaneous melanoma diagnosis and tumor burdens in Europe. A relevant literature search in electronic databases was conducted from inception to September 2022. The inclusion criteria were: controlled studies published in a peer-reviewed journal evaluating cutaneous melanoma in Europe and reporting data on melanoma characteristics from diagnoses. The quality of studies was evaluated using the Cochrane ROBINS-I tool for assessing bias in non-randomized studies. Meta-analysis was conducted utilizing a random effects model to synthesize the data. A total of 25 studies involving 32,231 patients were included in the data analysis models. Statistically significant increases in mean Breslow thickness (0.29 mm (0.03–0.55 mm)), ulceration rates (OR = 1.66 (1.29–2.13)), and resultant tumor staging were observed in the PostCovid group, with subgroup analysis revealing that lockdown-derived data were responsible for this trend. This meta-analysis reported on the impact of COVID-19 restrictions on melanoma diagnosis in Europe, emphasizing the higher tumor burden and disease progression state provoked by healthcare adaptations in the pandemic period.

show abstract

“…Indeed, several measures were adopted to contain the spread of the infection as well as to guarantee the continuity of care, particularly for the oncodermatological field [ 246 , 247 , 248 , 249 , 250 , 251 ] as well as for patients undergoing biological treatments [ 252 ]. In this scenario, dermatologists were involved and forced to change their clinical routine to guarantee the continuity of care for patients with chronic inflammatory disease undergoing biological or other systemic treatments as well as to avoid the reduction in the diagnosis and treatment of several conditions, mainly melanoma and non-melanoma skin cancer [ 251 , 252 , 253 , 254 ]. Teledermatological services were shown to be a useful tool in this context, allowing clinicians to continuously assist patients’ diseases with promising results in terms of clinical outcomes, patient satisfaction, and treatment adherence [ 255 , 256 ].…”

Section: Discussionmentioning

confidence: 99%

The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature

Fabbrocini

Battista

Ruggiero

et al. 2023

Viruses

Self Cite

View full text Add to dashboard Cite

Background: Four vaccines have been authorized by the European Medicines Agency (EMA): viral vector-based vaccines (AstraZeneca; AZD1222 and Johnson & Johnson; Ad26.COV2. and 2 mRNA-based vaccines (Pfizer/BioNTech; BNT162b2 and Moderna; mRNA-1273). Adverse events (AEs) related to vaccination have been described in the literature. The main aim of the dermatological practice was to avoid the diffusion of COVID-19, allowing the continuity of care for patients. Objective: The aim of this review article is to investigate current literature regarding cutaneous reactions following COVID-19 vaccination, mainly inflammatory dermatological diseases. Materials and methods: Investigated manuscripts included metanalyses, reviews, letters to the editor, real-life studies, case series, and reports. Results: We selected a total of 234 articles involving more than 550 patients. We have divided the results section into various sub-sections to ensure greater understanding for readers. Conclusions: Clinicians should keep in mind the possibility of new onsets or the worsening of several dermatoses following vaccination in order to promptly recognize and treat these AEs. Certainly, vaccination should not be discouraged.

show abstract

Effects of COVID‐19 pandemic on malignant melanoma diagnosis

Cited by 10 publications

References 7 publications

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

A Meta-Analysis on the Impact of the COVID-19 Pandemic on Cutaneous Melanoma Diagnosis in Europe

The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature

Contact Info

Product

Resources

About